Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michal Dranitzki, Elhalal"'
Autor:
Zakhar, Nudelman, Naama, Keshet, Michal Dranitzki, Elhalal, Michael, Friedman, Rakefet, Czerninski
Publikováno v:
Anticancer research. 33(2)
Sirolimus is a potent blocker of mammalian target of Rapamycin (MTOR), with anti proliferative activity. Its potential for the management of oral cancer has been suggested. Our aim was to establish an analytical method for determining sirolimus level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d4b2c96c3fca527d42c787f0f91d765
https://pubmed.ncbi.nlm.nih.gov/23393364
https://pubmed.ncbi.nlm.nih.gov/23393364
Autor:
Rakefet Czerninski, Michal Dranitzki Elhalal, Zakhar Nudelman, Michael Friedman, Naama Keshet
Publikováno v:
Oral Oncology. 49:S138
Purpose Sirolimus, currently used as an immunosuppressant, is a potent mammalian target of rapamycin blocker with antiproliferative activity. Its potential for the management of oral pathologies and cancer and has been suggested. Topical application
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9262c4ed3c2b0e4da195590845dbe0b8
https://doi.org/10.1016/j.oraloncology.2013.03.373
https://doi.org/10.1016/j.oraloncology.2013.03.373